Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers

Breastmilk contains antibodies that could protect breastfed infants from infections. In this work, we examined if antibodies in breastmilk could neutralize SARS-CoV-2 in 84 breastmilk samples from women that were either vaccinated (Comirnaty, mRNA-1273, or ChAdOx1), infected with SARS-CoV-2, or both infected and vaccinated. The neutralization capacity of these sera was tested using pseudotyped vesicular stomatitis virus carrying either the Wuhan-Hu-1, Delta, or BA.1 Omicron spike proteins. We found that natural infection resulted in higher neutralizing titers and that neutralization correlated positively with levels of immunoglobulin A in breastmilk. In addition, significant differences in the capacity to produce neutralizing antibodies were observed between both mRNA-based vaccines and the adenovirus-vectored ChAdOx1 COVID-19 vaccine. Overall, our results indicate that breastmilk from naturally infected women or those vaccinated with mRNA-based vaccines contains SARS-CoV-2 neutralizing antibodies that could potentially provide protection to breastfed infants from infection.

Saved in:
Bibliographic Details
Main Authors: Bäuerl, Christine, Zulaica, Joao, Rusu, Luciana, Moreno, Alicia Rodríguez, Pérez Cano, Francisco J., Lerin, Carles, Mena Tudela, Desirée, Aguilar Camprubí, Laia, Parra Llorca, Anna, Martínez-Costa, Cecilia, Geller, Ron, Collado, María Carmen
Other Authors: European Commission
Format: artículo biblioteca
Language:English
Published: Elsevier 2023-05-04
Subjects:Health sciences, Immune response, Public health, Virology, http://metadata.un.org/sdg/3, Ensure healthy lives and promote well-being for all at all ages,
Online Access:http://hdl.handle.net/10261/309716
http://dx.doi.org/10.13039/501100000780
http://dx.doi.org/10.13039/501100003339
http://dx.doi.org/10.13039/501100011033
https://api.elsevier.com/content/abstract/scopus_id/85159292872
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-iata-es-10261-309716
record_format koha
spelling dig-iata-es-10261-3097162024-10-27T21:48:32Z Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers Bäuerl, Christine Zulaica, Joao Rusu, Luciana Moreno, Alicia Rodríguez Pérez Cano, Francisco J. Lerin, Carles Mena Tudela, Desirée Aguilar Camprubí, Laia Parra Llorca, Anna Martínez-Costa, Cecilia Geller, Ron Collado, María Carmen European Commission Agencia Estatal de Investigación (España) Consejo Superior de Investigaciones Científicas (España) #NODATA# #NODATA# #NODATA# #NODATA# #NODATA# #NODATA# #NODATA# #NODATA# #NODATA# #NODATA# #NODATA# 0000-0002-6204-4864 Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] Health sciences Immune response Public health Virology http://metadata.un.org/sdg/3 Ensure healthy lives and promote well-being for all at all ages Breastmilk contains antibodies that could protect breastfed infants from infections. In this work, we examined if antibodies in breastmilk could neutralize SARS-CoV-2 in 84 breastmilk samples from women that were either vaccinated (Comirnaty, mRNA-1273, or ChAdOx1), infected with SARS-CoV-2, or both infected and vaccinated. The neutralization capacity of these sera was tested using pseudotyped vesicular stomatitis virus carrying either the Wuhan-Hu-1, Delta, or BA.1 Omicron spike proteins. We found that natural infection resulted in higher neutralizing titers and that neutralization correlated positively with levels of immunoglobulin A in breastmilk. In addition, significant differences in the capacity to produce neutralizing antibodies were observed between both mRNA-based vaccines and the adenovirus-vectored ChAdOx1 COVID-19 vaccine. Overall, our results indicate that breastmilk from naturally infected women or those vaccinated with mRNA-based vaccines contains SARS-CoV-2 neutralizing antibodies that could potentially provide protection to breastfed infants from infection. This work was supported by a research grant from LaMarató-TV3 (MilkCORONA, ref. 202106). MCC and RG are part of the CSIC's Global Health Platform (PTI+ Salud Global). Funding for this project was provided by grants from the European Commission NextGenerationEU fund (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI+ Salud Global) to RG. IATA-CSIC is a Centre of Excellence Severo Ochoa (CEX2021-001189-S) and INSA-UB is a Maria de Maeztu Unit of Excellence (CEX2021-001234-M) funded by MICIN/AEI/FEDER, UE. With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S) and Maria de Maeztu Unit of Excellence (CEX2021-001234-M) Peer reviewed 2023-05-26T07:28:18Z 2023-05-26T07:28:18Z 2023-05-04 artículo http://purl.org/coar/resource_type/c_6501 iScience 26(6): 106802 (2023) EX2021-001189-S CEX2021-001234-M http://hdl.handle.net/10261/309716 10.1016/j.isci.2023.106802 2589-0042 http://dx.doi.org/10.13039/501100000780 http://dx.doi.org/10.13039/501100003339 http://dx.doi.org/10.13039/501100011033 37197591 2-s2.0-85159292872 https://api.elsevier.com/content/abstract/scopus_id/85159292872 en #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/CEX2021-001189-S info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/CEX2021-001234-M iScience Publisher's version The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI 10.1016/j.isci.2023.106802 https://doi.org/10.1016/j.isci.2023.106802 Sí open application/pdf Elsevier
institution IATA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-iata-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del IATA España
language English
topic Health sciences
Immune response
Public health
Virology
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
Health sciences
Immune response
Public health
Virology
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
spellingShingle Health sciences
Immune response
Public health
Virology
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
Health sciences
Immune response
Public health
Virology
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
Bäuerl, Christine
Zulaica, Joao
Rusu, Luciana
Moreno, Alicia Rodríguez
Pérez Cano, Francisco J.
Lerin, Carles
Mena Tudela, Desirée
Aguilar Camprubí, Laia
Parra Llorca, Anna
Martínez-Costa, Cecilia
Geller, Ron
Collado, María Carmen
Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
description Breastmilk contains antibodies that could protect breastfed infants from infections. In this work, we examined if antibodies in breastmilk could neutralize SARS-CoV-2 in 84 breastmilk samples from women that were either vaccinated (Comirnaty, mRNA-1273, or ChAdOx1), infected with SARS-CoV-2, or both infected and vaccinated. The neutralization capacity of these sera was tested using pseudotyped vesicular stomatitis virus carrying either the Wuhan-Hu-1, Delta, or BA.1 Omicron spike proteins. We found that natural infection resulted in higher neutralizing titers and that neutralization correlated positively with levels of immunoglobulin A in breastmilk. In addition, significant differences in the capacity to produce neutralizing antibodies were observed between both mRNA-based vaccines and the adenovirus-vectored ChAdOx1 COVID-19 vaccine. Overall, our results indicate that breastmilk from naturally infected women or those vaccinated with mRNA-based vaccines contains SARS-CoV-2 neutralizing antibodies that could potentially provide protection to breastfed infants from infection.
author2 European Commission
author_facet European Commission
Bäuerl, Christine
Zulaica, Joao
Rusu, Luciana
Moreno, Alicia Rodríguez
Pérez Cano, Francisco J.
Lerin, Carles
Mena Tudela, Desirée
Aguilar Camprubí, Laia
Parra Llorca, Anna
Martínez-Costa, Cecilia
Geller, Ron
Collado, María Carmen
format artículo
topic_facet Health sciences
Immune response
Public health
Virology
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
author Bäuerl, Christine
Zulaica, Joao
Rusu, Luciana
Moreno, Alicia Rodríguez
Pérez Cano, Francisco J.
Lerin, Carles
Mena Tudela, Desirée
Aguilar Camprubí, Laia
Parra Llorca, Anna
Martínez-Costa, Cecilia
Geller, Ron
Collado, María Carmen
author_sort Bäuerl, Christine
title Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
title_short Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
title_full Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
title_fullStr Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
title_full_unstemmed Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
title_sort assessment of sars-cov-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
publisher Elsevier
publishDate 2023-05-04
url http://hdl.handle.net/10261/309716
http://dx.doi.org/10.13039/501100000780
http://dx.doi.org/10.13039/501100003339
http://dx.doi.org/10.13039/501100011033
https://api.elsevier.com/content/abstract/scopus_id/85159292872
work_keys_str_mv AT bauerlchristine assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT zulaicajoao assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT rusuluciana assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT morenoaliciarodriguez assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT perezcanofranciscoj assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT lerincarles assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT menatudeladesiree assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT aguilarcamprubilaia assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT parrallorcaanna assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT martinezcostacecilia assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT gellerron assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
AT colladomariacarmen assessmentofsarscov2neutralizingantibodytitersinbreastmilkfromconvalescentandvaccinatedmothers
_version_ 1816138476941213696